摘要 |
The present invention relates to novel hepcidin antagonists of formula (I), pharmaceutical compositions comprising them and the use thereof as medicaments for the use in the treatment of iron metabolism disorders, such as, in particular, iron deficiency diseases and anaemias, in particular anaemias in connection with chronic inflammatory diseases (ACD: anaemia of chronic disease and Al; anaemia of inflammation). |
申请人 |
VIFOR (INTERNATIONAL) AG;BUHR, WILM;BURCKHARDT, SUSANNA;DUERRENBERGER, FRANZ;FUNK, FELIX;GEISSER, PETER OTTO;CORDEN, VINCENT ANTHONY;COURTNEY, STEPHEN MARTIN;DAVENPORT, TARA;SLACK, MARK;RIDGILL, MARK PETER;YARNOLD, CHRISTOPHER JOHN;DAWSON, GRAHAM;BOYCE, SUSAN;ELLENBROEK, ALBERTUS ANTONIUS |
发明人 |
BUHR, WILM;BURCKHARDT, SUSANNA;DUERRENBERGER, FRANZ;FUNK, FELIX;GEISSER, PETER OTTO;CORDEN, VINCENT ANTHONY;COURTNEY, STEPHEN MARTIN;DAVENPORT, TARA;SLACK, MARK;RIDGILL, MARK PETER;YARNOLD, CHRISTOPHER JOHN;DAWSON, GRAHAM;BOYCE, SUSAN;ELLENBROEK, ALBERTUS ANTONIUS |